Lundbeck
HLUN-B.CO
#2582
Rank
โ‚น458.29 B
Marketcap
โ‚น480.92
Share price
-0.98%
Change (1 day)
21.79%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): โ‚น29.01

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is โ‚น30.16. In 2022 the company made an earnings per share (EPS) of โ‚น22.94 a decrease over its 2021 EPS that were of โ‚น51.52.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น29.0126.47%
2022โ‚น22.94-55.47%
2021โ‚น51.52-51.83%
2020โ‚น106.95-28.01%
2019โ‚น148.55-44.08%
2018โ‚น265.6551.94%
2017โ‚น174.84126.64%
2016โ‚น77.14-120.84%
2015-โ‚น370.195622.18%
2014-โ‚น6.47-110.03%
2013โ‚น64.48-28.08%
2012โ‚น89.65-52.1%
2011โ‚น187.16-1.31%
2010โ‚น189.6515.61%
2009โ‚น164.04